Celldex Therapeutics Inc
NASDAQ:CLDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
US |
|
Kinross Gold Corp
TSX:K
|
CA |
|
Tourindo Guide Indonesia PT Tbk
IDX:PGJO
|
ID |
|
S
|
Synopsys Inc
SWB:SYP
|
US |
|
Perpetua Resources Corp
TSX:PPTA
|
US |
|
TOPPAN Holdings Inc
SWB:TPX
|
JP |
|
Sino Hotels (Holdings) Ltd
HKEX:1221
|
HK |
Wall Street
Price Targets
CLDX Price Targets Summary
Celldex Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
CLDX
is 55.42 USD
with a low forecast of 24.24 USD and a high forecast of 94.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CLDX's stock price target?
Price Target
55.42
USD
According to Wall Street analysts, the average 1-year price target for
CLDX
is 55.42 USD
with a low forecast of 24.24 USD and a high forecast of 94.5 USD.
What is Celldex Therapeutics Inc's Revenue forecast?
Projected CAGR
356%
For the last 14 years the
compound annual growth rate for
Celldex Therapeutics Inc's revenue is
-12%.
The projected
CAGR
for the next 3 years is
356%.
